Concerned that FTA may cut access to medicines in India, rest of the developing world: Médecins Sans Frontières writes to EU

4 months ago 1
ARTICLE AD BOX
Exterior presumption    of the planetary  office  of Médecins Sans Frontières (MSF), an planetary   aesculapian  humanitarian non-governmental organisation of French origin

Exterior presumption of the planetary office of Médecins Sans Frontières (MSF), an planetary aesculapian humanitarian non-governmental organisation of French origin | Photo Credit: Getty Images

Médecins Sans Frontières (MSF), an planetary assistance organisation that provides exigency aesculapian assistance to populations successful distress successful much than 80 countries, has written to the European Union expressing its interest implicit the precocious announced EU-India Free Trade Agreement.

The radical said that the projected restrictive provisions volition person large effect for entree to medicines successful India and the remainder of the processing world. 

“We are acrophobic that the EU-India FTA whitethorn incorporate provisions with dire consequences for entree to medicines successful India and the remainder of the processing world,” MSF said successful its missive to the European Commissioner for Trade European Commission.

“They volition fortify and widen the monopoly rights of multinational pharmaceutical manufacturers astatine the disbursal of patients successful India and beyond,” the radical warned.

MSF has specifically expressed interest implicit information exclusivity that could efficaciously artifact compulsory licenses, patent word extensions, enforcement and borderline measures that question to detain imports oregon exports of bully suspected of infringing intelligence spot rights.

“For patients surviving successful India and each implicit the processing world, these provisions could mean the quality betwixt beingness oregon death. It is important that generic contention remains imaginable successful India. We impulse you to guarantee that the negotiations pb by the European Commission’s representatives, connected behalf of the European Union, bash not incorporate intelligence spot proposals that spell beyond the requirements of the TRIPS Agreement,” said Tido von Schoen-Angerer, Executive Director, Campaign for Access to Essential Medicines
Médecins Sans Frontières International. 

MSF has been providing antiretroviral therapy (ART) to radical surviving with HIV/AIDS (PLHAs) since 2000.

It said that portion some informal and ceremonial negotiations betwixt India and the EU towards the signing of a FTA are astir to conclude, the radical noted that India has played a pivotal relation successful supplying affordable generic versions of drugs utilized passim the processing world.

MSF for illustration sources implicit 80% of its antiretroviral medicines utilized successful its AIDS projects astir the satellite from India. The availability of fixed-dose operation therapy (or three-in-one pills) has revolutionised AIDS treatment, a information we person witnessed archetypal manus successful our ain programmes.

Providing this signifier of attraction adapted to resource-poor settings successful processing countries has lone been imaginable due to the fact that determination were nary patent constraints successful India connected putting these medicines unneurotic successful 1 tablet. Currently 92% of radical surviving with HIV connected attraction successful low- and middle-income countries usage generic antiretrovirals manufactured successful India. 

Since 2005, India has developed a patent instrumentality that balances the request of patients to entree life-saving medicines astatine affordable prices with pharmaceutical institution profits. 

Specifically, India’s Patents Act allows diligent groups and different funny parties to reason frivolous oregon abusive patenting done pre- oregon post-grant oppositions, and by defining stricter patentability criteria has prevented a signifier known arsenic evergreening wherever institution monopolies tin beryllium endlessly extended.

“We are acrophobic that the EU-India FTA whitethorn incorporate provisions that dismantle cause entree advancement and correspond a sizeable measurement backwards, with dire consequences for entree to medicines successful India and the remainder of the processing world,” the radical said.

It besides said that immoderate provisions which are portion of the dialog seeks to limit, and successful immoderate cases wholly block, generic competition. “Generic contention has proven to beryllium cardinal successful lowering the prices of medicines, thereby improving entree to medicines,” the missive said.

Published - February 05, 2026 12:14 p.m. IST

Read Entire Article